POPULARITY
189 episodes with caretalk
7 episodes with caretalk
2 episodes with caretalk
Send us Fan MailMore than 160 million Americans live in areas with a shortage of mental health providers. The clinicians who do show up are spending hours on documentation, compliance, and eligibility work that has nothing to do with patient care.Alon Joffe, Co-Founder and CEO of Eleos Health, joins host John Driscoll to discuss how AI is reducing administrative burden for behavioral health clinicians and why workflow efficiency is becoming critical for community health centers facing Medicaid funding challenges.
Send us Fan MailA triplet birth in the United States costs roughly $577,000. A twin birth runs about $155,000. For a self-insured employer, that cost hits the bottom line directly.In this clip from our episode “Making Fertility Benefits An Employer Priority”, host David E. Williams and David Stern, CEO of Kindbody, break down how Kindbody puts skin in the game with employers through contractual guarantees on multiple birth rates, miscarriage rates, and time to care.Listen to the full episode here
Send us Fan MailFertility benefits have gone from a Silicon Valley recruiting perk to a boardroom priority in under a decade. Employers are no longer just offering access. They are demanding measurable outcomes, transparent costs, and clinical accountability.David Stern, CEO of Kindbody, joins host David E. Williams to discuss why the vertically integrated model of combining a fertility benefit manager with owned clinics is producing better outcomes for employers and patients alike, and what it means that a company serving Walmart employees in rural Arkansas is now one of the most important access stories in American reproductive medicine.
Send us Fan MailAmerican healthcare spends an estimated $110 per member per month just to administer itself, before a single service is ever delivered. Most of that cost exists because health data still cannot move freely between the systems that need it.Michael Meucci, CEO of Arcadia, joins host John Driscoll to discuss why two decades of interoperability policy have failed to solve the data fragmentation problem facing health systems and payers, and why liberating that data and redirecting the administrative spend it currently requires could be the single biggest lever available for improving both the cost and quality of American healthcare.
Send us Fan MailEighty-one percent of physicians are already using AI in practice, more than double the rate from just three years ago. The tools are moving faster than the rules, and nobody has agreed on who gets to write them.Dr. John Whyte, CEO of the American Medical Association, joins hosts David E. Williams and John Driscoll to discuss why the medical community needs to lead the conversation on AI guardrails rather than wait for Washington to catch up, and why the most urgent regulatory question right now involves AI chatbots in mental health, where one in six American adults are already using them with no meaningful oversight in place.
Send us Fan MailThere are very few cures for cancers that have already spread. So what does a good outcome actually look like?In this clip from our episode “How Targeted Radiotherapy Is Changing Cancer Care”, host David E. Williams and John Babich, Founder, President, and Chief Scientific Officer of Ratio Therapeutics, break down what extending life with quality really means in cancer care, and why giving someone eight more months where they can still live their life is the philosophy driving the work at Ratio Therapeutics.Listen to the full episode here
Send us Fan MailFor decades, cancer treatment has rested on three pillars: surgery, chemotherapy, and external beam radiation. A fourth is now taking shape, and it is drawing billions in investment from some of the largest pharmaceutical companies in the world.John Babich, Founder, President, and Chief Scientific Officer of Ratio Therapeutics, joins host David E. Williams to explain how targeted radiotherapeutics pair a tumor-seeking molecule with a radioactive payload, delivering radiation to cancer cells while sparing healthy tissue. He also unpacks what Pluvicto's success in prostate cancer signals for the future of radioligand therapy.
Send us Fan MailNobody at the pharmacy counter knows the real price of their medication, and almost nobody in the system actually wants them to.Mark Cuban, Co-Founder of Cost Plus Drugs, joins host John Driscoll on CareTalk to discuss why pharmacy benefit managers control 85% of drug formularies in this country, how spread pricing quietly inflates the cost of everything from generics to hip replacements, and why true price transparency, not just lower prices, is the real disruption Cost Plus Drugs has brought to a $5 trillion industry.
Send us Fan MailGLP-1 drugs have produced some of the most consistent weight loss results medicine has ever seen. The business of actually getting them to patients is a different story entirely.David E. Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, break down the CVS Caremark formulary reversal on CareTalk, examining what it reveals about the economics of GLP-1 coverage, and why emerging clinical research on cancer, long COVID, and addiction may push these drugs far beyond their original indication.
Send us Fan MailSix million healthcare workers are missing today. By 2030, that number reaches 10 million. No amount of training will ever close that gap.In this clip from our episode “Is AI the New Dr. Google?”, host David E. Williams and Bertalan Mesko, Director of the Medical Futurist Institute, break down why the healthcare worker shortage is a mathematical problem that only advanced technology can solve.
Send us Fan MailThe World Health Organization projects a global shortage of 10 million healthcare workers by 2030. No training pipeline can close that gap. The only path forward runs through technology.Dr. Bertalan Meskó, Founder & Director of the Medical Futurist Institute, joins host David E. Williams to discuss why digital health is first and foremost a cultural transformation rather than a technological one, and why the most important thing any health system leader can do right now is learn how to use AI as the connective interface between an increasingly complex ecosystem of tools, patients, and clinical teams.
Send us Fan MailThe liver is the only organ in the body that can release stored glucose to prevent low blood sugar. So why has injected insulin never been able to reach it?In this clip from our episode “Finding a Solution for GLP-1 Side Effects”, host David E. Williams and Bob Geho, Founder and CEO of Diasome, break down the biological gap at the heart of diabetes treatment and how a father's decades of research into liver-targeted insulin delivery became the founding idea behind Diasome.
Send us Fan MailEvery year, one in five adults with Type 1 diabetes experiences a dangerous drop in blood sugar that renders them unable to treat themselves. These severe hypoglycemic events are still happening, even though many patients now use continuous glucose monitors and automated insulin pumps.Why has this trade-off between long-term A1C control and dangerous sugar crashes persisted for over 30 years?Bob Geho, Founder and CEO of Diasome, joins host David E. Williams to unpack the results of the company's 200+ patient Phase 2B OPTI-2 trial of HDV™ insulin. The study was presented recently at the American Diabetes Association meeting in New Orleans.In the trial, five patients using standard insulin experienced severe hypoglycemic events. This compares with zero such events among patients receiving HDV™ insulin. Meanwhile, HDV™ insulin matched standard-of-care A1C control.Bob also shares how the HDV platform is being studied for its potential to reduce side effects in GLP-1 therapy and to address insulin resistance, considered the root cause of Type 2 Diabetes.
Send us Fan MailFor years, hospitals managing value-based contracts have been doing so with one hand tied behind their back, defaulting to Medicare logic because that was the only playbook precise enough to follow.In this clip from our episode “Why Value-Based Care Is Finally Hitting Its Tipping Point”, host David E. Williams and David Snow, Chairman & CEO of Cedar Gate Technologies, an IQVIA business, break down why that era of generalization is over and what precision contract analytics actually makes possible now.Listen to the full episode here
Send us Fan MailFor decades, value-based care has been healthcare's promised future. Most health systems have stayed in upside-only arrangements, and the data infrastructure needed to manage real risk has never quite caught up to the ambition.That may finally be changing. David Snow, Chairman & CEO of Cedar Gate Technologies, an IQVIA business, joins host David E. Williams to discuss why CMS's first mandatory bundled payment model signals the end of voluntary experimentation, and why the fragmented data problem that has undermined value-based care for a generation is only now finding a real solution.
Send us Fan MailThe collapse of Dr. Casey Means' nomination this week has sent shockwaves through the “Make America Healthy Again” (MAHA) movement. While the tech world debates AI, healthcare is debating the “Saphier Pivot,” the Trump administration's sudden shift from a radical MAHA outsider to a credentialed Fox News regular. With the Surgeon General's office at a crossroads, we have to ask: is the role still a beacon of public health, or has it become the ultimate prize in the culture war?John Driscoll, Chairman of UConn Health and David E. Williams, President of Health Business Group, diagnose the state of the Surgeon General's office, examining what the rapid pivot to Dr. Nicole Saphier reveals about the limits of MAHA's political power, and whether the nation's most visible public health platform can still move the needle in an era of historic distrust in federal health agencies.
Send us Fan MailIs American healthcare collapsing?In this clip from our episode "How AI Could Save a Collapsing Healthcare System," host David E. Williams and Dr. Robert Pearl, Author of ChatGPT MD, break down why the current system is financially unsustainable and why physicians have never had the tools to fight back. Until now.Listen to the full episode here
Send us Fan MailAmerican employers now spend over $25,000 a year to cover a single family, and chronic disease is driving the system toward collapse. Yet medicine is still built around a doctor's office visit every three to four months.Dr. Robert Pearl, former CEO of the Permanente Medical Group, Stanford professor, and author of ChatGPT MD, joins host David E. Williams to make the case that generative AI is the only tool that can shift medicine from episodic to continuous care, and why without it, the chronic disease crisis will break American healthcare entirely.
Send us Fan MailIs the era of just managing Parkinson's symptoms finally coming to an end?In this clip from our episode “How AI Is Helping The Fight Against Parkinson's”, host David E. Williams and guest Gene Mack, CEO of Gain Therapeutics, share why the early signals from their lead drug candidate are too compelling to ignore.Listen to the full episode here
Send us Fan MailFor decades, Parkinson's patients have been offered only symptom management. No drug has ever slowed the disease itself. A small clinical stage biotech may be about to change that.Gene Mack, CEO, Gain Therapeutics joins host David E. Williams to discuss the science behind a potential first disease modifying therapy for Parkinson's, how AI is accelerating drug discovery, and what it takes to build a biotech in one of the toughest capital markets in years.
Send us Fan MailIf you or someone you love just received a cancer diagnosis, what are the first three things you need to know?In this clip from our episode “Can AI Help Us Finally Beat Cancer”, host John Driscoll and guest Dr. Sanjay Juneja, TheOncDoc, walk through the essential steps every cancer patient should take immediately after diagnosis.Listen to the full episode here
Send us Fan MailWhat if food worked better than medication for managing diabetes?In this clip from our episode “Food As Medicine: From Trend to Treatment”, CareTalk host John Driscoll and guest Spencer Pratt, Chief Growth Officer at NourishedRx, share the clinical data behind their food as medicine approach to diabetes care.
Send us Fan MailFood as medicine is moving from buzzword to real healthcare strategy.In this CareTalk episode, Spencer Pratt, Chief Growth Officer of NourishedRx, explains why nutrition is finally getting the policy, payer, and consumer support needed to impact chronic disease at scale.
Send us Fan MailIs American primary care already past the point of no return?In this clip from our episode “Why US Healthcare is Fundamentally Broken”, host David E. Williams and guest Zeev Neuwirth, Head of Strategic Partnerships at Rezilient Health, confront a stark reality about where primary care spending stands today.
Send us Fan MailPrimary care is on life support. Administrative burden is crushing physicians, employer healthcare is broken, and decades of reform efforts have barely moved the needle. So what does real transformation actually look like?Zeev Neuwirth, Head of Strategic Partnerships, Rezilient Health joins host David E. Williams to discuss why the American healthcare system keeps failing despite enormous resources, what direct primary care and employer contracting can do differently, and why GLP-1s without lifestyle medicine may be a costly mistake.
Send a textHow should healthcare leaders approach AI without getting swept up in the hype?In our recent episode of CareTalk, "Is AI Coming for Healthcare Jobs?", hosts David E. Williams and John Driscoll break down why healthcare leaders need to stop avoiding the AI conversation and start engaging with it seriously.Listen to the full episode here
Send a textThe wellness industry is booming, but is it actually helping people live better lives? With trillions spent on supplements, special diets, and longevity hacks, it raises a bigger question about what really matters for long-term health.Dr. Zeke Emanuel, Author, Eat Your Ice Cream joins CareTalk to discuss the wellness industrial complex, the health risks of loneliness, and why social connection, simple habits, and even ice cream may matter more than expensive longevity obsessions.
Send a textHow can patients and providers trust AI in healthcare if they don't understand how it works? In this clip from our episode "Making Healthcare Access Truly Borderless”, HealthBiz Podcast host David Williams speaks with Dr. Sarah Matt, author of The Borderless Healthcare Revolution, about why explainability and trust matter when AI is used in care delivery.Listen to the full episode here
Send a textHealthcare access is often treated as a technology problem, but the real barriers run much deeper. Geography, cost, culture, trust, and digital readiness all shape whether patients can actually get the care they need. Without addressing the system as a whole, even the most advanced tools risk leaving people behind.Sarah Matt, Author of The Borderless Healthcare Revolution, joins the HealthBiz Podcast to discuss what it truly takes to break down geographic barriers in healthcare, why access must be designed into systems from the start, and how technology can support care without replacing the human connection at its core.
Send a textIs being inactive more dangerous than we think? In this clip from our episode “Why Exercise Beats Longevity Hacks”, CareTalk host John Driscoll speaks with Dr. Jordan Metzl, Author of The Athlete's Book of Home Remedies, about why movement may be the most powerful preventive medicine we have, even in the era of GLP-1s.Listen to the full episode here
Send us a textThe longevity boom is full of supplements, hacks, and expensive routines, but most of it ignores the simplest lever we already know works. If movement is the most studied “drug” for healthy aging, why are so many people still stuck on the sidelines?Dr. Jordan Metzl, Author of The Athlete's Book of Home Remedies joins CareTalk host John Driscoll, Chairman of UConn Health, to discuss why exercise is the most powerful prescription for healthspan, how motivation can be built through practical behavior change, and how strength and community can help prevent chronic disease over the long run.
Send us a textDemand for GLP-1 medications has exploded in recent years. What started as a diabetes treatment has quickly become one of the most talked-about forces in healthcare, reshaping how we think about obesity, metabolic disease, access, affordability, and long-term care.But with rapid growth comes confusion: questions about safety, cost, supply constraints, and whether the current system is actually capable of supporting patients for the long haul.Dr. Myra Ahmad, Founder and CEO of Mochi Health joins CareTalk host David E. Williams to discuss what's getting lost in the GLP-1 conversation, why most care models are not built for long-term obesity treatment, and how Mochi is approaching physician-guided metabolic care at scale.
Send us a textHow deep into AI do clinicians really need to go? In this clip from our episode "Making Healthcare Massively Better", CareTalk host John Driscoll speaks with Halle Tecco about why becoming AI-literate is the only way to build real guardrails as patients use tools like ChatGPT at scale.Listen to the full episode here
Send us a textHealthcare innovation has never had more hype or more pressure to deliver real results. With AI accelerating and digital health entering a more mature phase, what does “better” actually look like in practice? Halle Tecco, Author of Massively Better Healthcare joins CareTalk host John Driscoll, Chairman of UConn Health, to discuss what Silicon Valley gets right and wrong about healthcare, why innovators need to align incentives with outcomes, and how leaders should think about AI with clear guardrails instead of buzzwords.
Send us a textAre GLP-1 drugs becoming a long-term foundation of healthcare? In this clip from our episode "What JPM Signals for Healthcare in 2026", CareTalk hosts David Williams and John Driscoll discuss why GLP-1s may be evolving beyond short-term weight loss treatments.Listen to the full episode here
Send us a textWill AI actually replace jobs in healthcare, or change what people work on? In this clip from our episode Top Insights From JPM Conference 2026, CareTalk hosts David Williams and John Driscoll discuss why concerns about job loss came up at JPM, and how industry leaders are instead focusing on the new kinds of work AI could enableListen to the full episode here
Send us a textUnsurprisingly, AI dominated the headlines at this year's JPMorgan Healthcare Conference, but there were some other exciting developments that shouldn't be overlooked.CareTalk hosts, David Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, share their on-the-ground insights from JPM, including where AI is delivering substance over hype, why government partnership will play a larger role in health sector reform, and what's driving a renewed sense of optimism across healthcare.
Send us a textWhat does truly personalized cancer care actually look like in the years ahead? In this clip from our episode “When AI Spots What Doctors Miss”, HealthBiz Podcast host David Williams speaks with Steve Brown, Founder and CEO of CureWise, about how AI and full-genome sequencing could enable truly individualized cancer treatment. Listen to the full episode here
Send us a textReferrals are meant to connect patients to the care they need, but in reality, they often become a source of delays, dropped handoffs, and administrative chaos. Between intake complexity, missing information, and outdated processes, too many patients get stuck between diagnosis and treatment. Trey Holterman, Co-Founder and CEO of Tennr joins CareTalk host John Driscoll to discuss why referrals break down so often, what makes intake workflows so hard to fix, and how health systems can improve throughput and access without ripping out the systems they already rely on.
Send us a textModern medicine generates more data than any one clinician or patient can reasonably process, and for people with rare or complex conditions, that gap can mean delayed diagnoses, missed options, and life-altering consequences. As precision medicine advances, the challenge is no longer just having information, but making it understandable and usable when it matters most.Steve Brown, Founder & CEO of CureWise, joins HealthBiz Podcast host David Williams to discuss how AI helped uncover his own missed cancer diagnosis and why patients need better tools to understand their own medical data.
Send us a text2025 has been another whirlwind year for healthcare. Between the new Administration upending the apple care, the explosion of AI, and the continued march of GLP-1s, the landscape has shifted under our feet.Will things settle down in 2026 or become even more volatile? Hosts David E. Williams and John Driscoll join CareTalk to share their predictions for 2026, discussing how AI will evolve, why affordability will dominate the conversation, what may change in drug pricing and value-based care, and how policy decisions could ripple across the healthcare system.w
Send us a textFederally Qualified Health Centers (FQHCs) care for more than 30 million Americans, yet many people have never heard of them or understand how they stay afloat. A major piece of their financial survival is the 340B drug pricing program, which has quietly become one of the most important funding mechanisms in the safety net and it is under growing pressure.Scott Seidelmann, CEO of Nuvem, joins CareTalk hosts David E. Williams and John Driscoll to discuss how FQHCs serve underserved communities, why 340B has become essential to their operations, and what policy changes could make or break their ability to deliver care.
Send us a textLung cancer is often discovered too late, when treatments are expensive and survival rates are low. But what if routine chest x-rays could flag cancer early…long before symptoms appear? AI is transforming everyday imaging into a powerful early detection tool, reshaping screening economics and saving lives around the world. Prashant Warier, CEO and Founder of Qure.ai, joins CareTalk to discuss how AI enables earlier diagnosis, why chest x-rays are an untapped opportunity for detection, and what it takes to integrate AI into national health systems at scale.
Send us a textHealth insurance in the United States is incredibly complex, filled with deductibles, co-pays, co-insurance, narrow networks and more. Why is our system such a maze? Is it the unintended product of decades of patchwork policies, or is the complexity intentional?In this episode of CareTalk, hosts David E. Williams and John Driscoll break down the real reasons health insurance is so hard to navigate, exploring the structural fragmentation of the system, the role of intermediaries like PBMs and brokers, the impact of convoluted billing practices, and what meaningful simplification would actually look like.
Send us a textIf you don't know where the patient's data is at every moment, you really can't protect it yet. That's the reality many healthcare organizations are facing. Regulations can help but legacy siloed systems keep patients exposed.In this episode of the HealthBiz Podcast, David Williams is joined by Aimee Cardwell, CISO-in-residence at Transcend. Aimee breaks down why compliance doesn't equal security, how legacy architectures and vendor ecosystems create hidden vulnerabilities, and what modern, identity-centric, AI-enabled security should look like.
Send us a textAI assistants like transcription co-pilots and chat-bots are yesterday's news. Now, we're entering the new era of agentic AI. The new tools are powerful but a little unsettling. AI giving advice is one thing, but are we ready for AI to take action on our behalf?In this episode of CareTalk, hosts John Driscoll and David Williams explore the dawn of agentic AI, systems that act autonomously to perform complex tasks, including in healthcare.
Send us a textHealthcare is drowning in messy, inconsistent data, and IMO Health is helping clean it up so organizations can turn information into real clinical insight.In this CareTalk Executive Feature episode, host David E. Williams speaks with John Laursen, Senior Vice President of Commercialization at IMO Health, about how to separate hype from real value in AI healthcare.
Send us a textWhat if rural hospitals could thrive instead of just survive?In this episode of CareTalk Executive Features, WVU Medicine President & CEO Albert L. Wright, Jr. joins host David Williams to share how the health system is redefining rural healthcare, expanding access, advancing innovation, and aligning care delivery through initiatives like Peak Health.
Send us a textVaccines save lives, misinformation spreads fast, and ice cream, believe it or not, might actually be good for you.In this episode of CareTalk, Dr. Zeke Emanuel joins John Driscoll to discuss vaccine myths, public health confusion, and how the healthcare system can communicate science more effectively.
Send us a textWill the $50 billion rural transformation fund save rural hospitals or hasten their demise? In this episode of CareTalk, hosts David E. Williams and John Driscoll debate whether CMS's plan to reshape rural healthcare can actually work.
© 2020-2026 Ivy Podcast Discovery LLC
